Clinical Trial Update: A Study to Evaluate ART101 in Adult Participants With Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating ART101 in adults with hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• ART101

Snippet

Sponsor: Arnatar Therapeutics, Inc. | Conditions: Hypertension | Phase 1 | Status: TERMINATED